<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04670000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P00374</UniProt_ID>
  <Seq_Length>187</Seq_Length>
  <Molecule_Weight>21453</Molecule_Weight>
  <KEGG_ID>hsa:1719</KEGG_ID>
  <Orthology_ID>K00287</Orthology_ID>
  <Function_Summary>Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis. Binds its own mRNA and that of DHFRL1.</Function_Summary>
  <Catalytic_Mechanism>5,6,7,8-tetrahydrofolate + NADP(+) = 7,8-dihydrofolate + NADPH.</Catalytic_Mechanism>
  <Pfam_ID>PF00186:DHFR_1</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.</Detail>
      <Keyword>Drug binding</Keyword>
      <Ontology_ID>GO:0008144</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with pre-messenger RNA (pre-mRNA) or messenger RNA (mRNA).</Detail>
      <Keyword>MRNA binding</Keyword>
      <Ontology_ID>GO:0003729</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA molecule or a portion thereof.</Detail>
      <Keyword>RNA binding</Keyword>
      <Ontology_ID>GO:0003723</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: 5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+.</Detail>
      <Keyword>Dihydrofolate reductase activity</Keyword>
      <Ontology_ID>GO:0004146</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.</Detail>
      <Keyword>NADP binding</Keyword>
      <Ontology_ID>GO:0050661</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>153</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>80</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).</Detail>
      <Keyword>Nucleotide biosynthetic process</Keyword>
      <Ontology_ID>GO:0009165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.</Detail>
      <Keyword>Tetrahydrofolate metabolic process</Keyword>
      <Ontology_ID>GO:0046653</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving the transfer of one-carbon units in various oxidation states.</Detail>
      <Keyword>One-carbon metabolic process</Keyword>
      <Ontology_ID>GO:0006730</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the activity of the enzyme nitric-oxide synthase.</Detail>
      <Keyword>Regulation of nitric-oxide synthase activity</Keyword>
      <Ontology_ID>GO:0050999</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methotrexate stimulus. Methotrexate is 4-amino-10-methylformic acid, a folic acid analogue that is a potent competitive inhibitor of dihydrofolate reductase.</Detail>
      <Keyword>Response to methotrexate</Keyword>
      <Ontology_ID>GO:0031427</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of glycine, aminoethanoic acid.</Detail>
      <Keyword>Glycine biosynthetic process</Keyword>
      <Ontology_ID>GO:0006545</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.</Detail>
      <Keyword>Folic acid metabolic process</Keyword>
      <Ontology_ID>GO:0046655</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.</Detail>
      <Keyword>Nitric oxide metabolic process</Keyword>
      <Ontology_ID>GO:0046209</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that regulates transcription such that the target genes are transcribed as part of the G1/S phase of the mitotic cell cycle.</Detail>
      <Keyword>Regulation of transcription involved in G1/S phase of mitotic cell cycle</Keyword>
      <Ontology_ID>GO:0000083</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND</Protein_Seq>
    <DNA_Seq>TCCCAGACAGAACCTACTATGTGCGGCGGCAGCTGGGGCGGGAAGGCGGGAGCTGGGGGCGCTGGGGGCGCTGCGGCCGCTGCGGCCGCTGCAGCCGCTGCAGCGCCAGGGTCCACCTGGTCGGCTGCACCTGTGGAGGAGGAGGTGGATTTCAGGCTTCCCGTAGACTGGAAGAATCGGCTCAAAACCGCTTGCCTCGCAGGGGCTGAGCTGGAGGCAGCGAGGCCGCCCGACGCAGGCTTCCGGCGAGACATGGCAGGGCAAGGATGGCAGCCCGGCGGCAGGGCCTGGCGAGGAGCGCGAGCCCGCGGCCGCAGTTCCCAGGCGTCTGCGGGCGCGAGCACGCCGCGACCCTGCGTGCGCCGGGGCGGGGGGGCGGGGCCTCGCCTGCACAAATGGGGACGAGGGGGGCGGGGCGGCCACAATTTCGCGCCAAACTTGACCGCGCGTTCTGCTGTAACGAGCGGGCTCGGAGGTCCTCCCGCTGCTGTCATGGTTGGTTCGCTAAACTGCATCGTCGCTGTGTCCCAGAACATGGGCATCGGCAAGAACGGGGACCTGCCCTGGCCACCGCTCAGGAATGAATTCAGATATTTCCAGAGAATGACCACAACCTCTTCAGTAGAAGGTAAACAGAATCTGGTGATTATGGGTAAGAAGACCTGGTTCTCCATTCCTGAGAAGAATCGACCTTTAAAGGGTAGAATTAATTTAGTTCTCAGCAGAGAACTCAAGGAACCTCCACAAGGAGCTCATTTTCTTTCCAGAAGTCTAGATGATGCCTTAAAACTTACTGAACAACCAGAATTAGCAAATAAAGTAGACATGGTCTGGATAGTTGGTGGCAGTTCTGTTTATAAGGAAGCCATGAATCACCCAGGCCATCTTAAACTATTTGTGACAAGGATCATGCAAGACTTTGAAAGTGACACGTTTTTTCCAGAAATTGATTTGGAGAAATATAAACTTCTGCCAGAATACCCAGGTGTTCTCTCTGATGTCCAGGAGGAGAAAGGCATTAAGTACAAATTTGAAGTATATGAGAAGAATGATTAATATGAAGGTGTTTTCTAGTTTAAGTTGTTCCCCCTCCCTCTGAAAAAAGTATGTATTTTTACATTAGAAAAGGTTTTTTGTTGACTTTAGATCTATAATTATTTCTAAGCAACTAGTTTTTATTCCCCACTACTCTTGTCTCTATCAGATACCATTTATGAGACATTCTTGCTATAACTAAGTGCTTCTCCAAGACCCCAACTGAGTCCCCAGCACCTGCTACAGTGAGCTGCCATTCCACACCCATCACATGTGGCACTCTTGCCAGTCCTTGACATTGTCGGGCTTTTCACATGTTGGTAATATTTATTAAAGATGAAGATCCACATACCCTTCAACTGAGCAGTTTCACTAGTGGAAATACCAAAAGCTTCCTACGTGTATATCCAGAGGTTTGTAGATAAATGTTGCCACCTTGTTTGTAACAGTGAAAAATTGAAAACAACCTGGAAGTCCAGTGATGGGAAAATGAGTATGTTTCTGTCTTAGATTGGGGAACCCAAAGCAGATTGCAAGACTGAAATTTCAGTGAAAGCAGTGTATTTGCTAGGTCATACCAGAAATCATCAATTGAGGTACGGAGAAACTGAACTGAGAAGGTAAGAAAAGCAATTTAAAGTCAGCGAGCAGGTTCTCATTGATAACAAGCTCCATACTGCTGAGATACAGGGAAATGGAGGGGGGAAAGCTGGAGTATTGATCCCGCCCCCCTCCTTGGTTGTCAGCTCCCTGTCCTGTGTGTGGGCGGAACATAGTCCAGCTGCTCTATAGCAAGTCTCAGGTGTTTGCAGTAAGAAGCTGCTGGCATGCACGGGAACAGTGAATGCCAAACACTTAAAGCAATTCGATGTTTAAGTATGTAAGTTCTTTTTTTTTTAGACAGCGTTTCGCTCTTGTTGCCCAGGCTAGCATGCAATGGTGTGACCTCGGCTTACTGCAACCTCCGCCTTCCCAGATTCAAGCGATTCTCCTGCCTCAGGCTCCCAAGTAGCTAGGACCAGGTGCGCGCCACCACGCCCGGCTAATTTTTGTATTTTGTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGTCAGGCTAGTCTCGAACTCGTGACCGCAAGCGATTCACCCACCTCAGCCTCCCAAAGTGCTGGGATTACCGGCTTGAGCCACCACACCCGGCACATCTTCATTCTTTTTATGTAGTAAAAAGTATAAGGCCACACATGGTTTATTTGAAGTATTTTATAATTTAAAAAAATACAGAAGCAGGAAAACCAATTATAAGTTCAAGTGAGGGATGATGGTTGCTTGAACCAAAGGGTTGCATGTAGTAAGAAATTGTGATTTAAGATATATTTTAAAGTTATAAGTAGCAGGATATTCTGATGGAGTTTGACTTTGGTTTTGGGCCCAGGGAGTTTCAGATGCCTTTGAGAAATGAATGAAGTAGAGAGAAAATAAAAGAAAAACCAGCCAGGCACAGTGGCTCACACCTGTAATCCCAGCGCTTTGGGAGGCTAAGGCAGGCAGATCACTTGAGACCAGCTTGGGCAACATGGCAAAGCCCCATCTCTACAAAAAACACAAAAATTAGCTGGGCATTGTGGCGCACACCTGTATTCCCATCTAGTCAGGAAGCTGAGATGGAAGAATTAATTGAGCCCACGAGTTCAAGGCTGCAGTGAGTCGTGATTGTGCCACTGCACTCCAGCCGGGGTGACAGAAGAGACCTTGTCTCGAAAAGGAATCTGAAAACAATGGAACCATGCCTTCATAATTCTAGAAAGTTATTTTCAACTGATAAATCTATATTCACCCAAATAATCAAGGGTGAAGGTAAAATAATACATTTTTAGACAAGCAAAGACTCAGGGGTTACCTCCATGTGCCCTTTTTAGGGAAGCTGTTGGAGAAAATACTCCAGCAAAATGAAGGAGTACACAAACCAGAGAATGACATGAATCCAGCAAATAGGATCCAACACAGGCAATATTCCAGCTATGGAGCTAGCTTTAAAAAGGAACAGTAAAAATATTAATCGGTTAGCTGGGTGGAATGGCCCATGCCTGTAGTCCCAGCTACTCAGGAGGCTCAGCAGCAGGACGACTTGAGCCCAAGAGTTCCAGACCAGCCTGGCCACCTTAGTGAGATCCCTTCTCTTAAAAATAATAACTTATTGCCAGATTTGGGGCATTTGGAAAGAAGTTCATTGAAGATAAAGCAAAAGTAAAAAAAAAAAAAAAAAAAACAAGGGGAAAGGGTTGGTTAGGCAATCATTCTAGGGCAGAAAGAAGTACAGGATAGGAAGAGCATAATACACTGTTTTTCTCAACAAGGAGCAGTATGTACACAGTCATAATGATGTGACTGCTTAGCCCCTAAATATGGTAACTACTCTGGGACAATATGGGAGGAAAAGTGAAGATTGTGATGGTGTAAGAGCTAAATCCTCATCTGTCATATCCAGAAATCACTATATAATATATAATAATGAAATGACTAAGTTATGTGAGGAAAAAAACAGAAGACATTGCTAAAAGAGTTAAAAGTCATTGCTCTGGAGAATTAGGAGGGATGGGGCAGGGGACTGTTAGGATGCATTATAAACTGAAAAGCCTTTTTAAAATTTTATGTATTAATATATGCATTCACTTGAAAAACTAAAAAAAAACAATAATTTGGAAAAACCCATGAAGGTAACTAACGGAAGGAAAAACTAAGAGAATGAAAAGTATTTGCCTCTGGAAAGAACAACTGGCAGGACTGTTGTTTTCATTGTAAGACTTTTGGAGCCATTTAATTGTACTTAACCATTTTCATCTATTTCTTTAATAAGAACAATTCCATCTTAATAAAGAGTTACACTTGTTAATAAGTAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleoplasm</CellLocal>
      <Ontology_ID>GO:0005654</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>DHFR</Gene_Name>
    <Gene_ID>1719</Gene_ID>
    <Genbank_ACCN>NM_000791</Genbank_ACCN>
    <Protein_ACCN>NP_000782</Protein_ACCN>
    <HGNC_ID>2861</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1719</Gene_URL>
    <UCSC_ID>uc003kgy.1</UCSC_ID>
    <EMBL_ID>ENSG00000228716</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Tetrahydrobiopterin Deficiency</Disease_Name>
      <Disease_Detail>Tetrahydrobiopterin Deficiency</Disease_Detail>
      <Disease_DB>TTR005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tetrahydrobiopterin_deficiency?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Megaloblastic Anemia Due to Dihydrofolate Reductase Deficiency</Disease_Name>
      <Disease_Detail>Megaloblastic Anemia</Disease_Detail>
      <Disease_DB>MGL012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/megaloblastic_anemia_due_to_dihydrofolate_reductase_deficiency?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pneumocystosis</Disease_Name>
      <Disease_Detail>Pneumocystosis</Disease_Detail>
      <Disease_DB>PNM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pneumocystosis?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteosarcoma</Disease_Name>
      <Disease_Detail>Osteosarcoma</Disease_Detail>
      <Disease_DB>OST018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteosarcoma?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pediatric Osteosarcoma</Disease_Name>
      <Disease_Detail>Pediatric Osteosarcoma</Disease_Detail>
      <Disease_DB>PDT021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pediatric_osteosarcoma?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Toxoplasmosis</Disease_Name>
      <Disease_Detail>Toxoplasmosis</Disease_Detail>
      <Disease_DB>TXP001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/toxoplasmosis?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Isosporiasis</Disease_Name>
      <Disease_Detail>Isosporiasis</Disease_Detail>
      <Disease_DB>ISS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/isosporiasis?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Homocysteine Plasma Level</Disease_Name>
      <Disease_Detail>Homocysteine Plasma Level</Disease_Detail>
      <Disease_DB>HMC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/homocysteine_plasma_level?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cerebral Folate Deficiency</Disease_Name>
      <Disease_Detail>Cerebral Folate Deficiency</Disease_Detail>
      <Disease_DB>CRB070</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cerebral_folate_deficiency?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cryptosporidiosis</Disease_Name>
      <Disease_Detail>Cryptosporidiosis</Disease_Detail>
      <Disease_DB>CRY003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cryptosporidiosis?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Megaloblastic Anemia</Disease_Name>
      <Disease_Detail>Megaloblastic Anemia</Disease_Detail>
      <Disease_DB>MGL001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/megaloblastic_anemia?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chagas Disease</Disease_Name>
      <Disease_Detail>Chagas Disease</Disease_Detail>
      <Disease_DB>CHG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chagas_disease?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spina Bifida</Disease_Name>
      <Disease_Detail>Spina Bifida</Disease_Detail>
      <Disease_DB>SPN038</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spina_bifida?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Stenotrophomonas Maltophilia</Disease_Name>
      <Disease_Detail>Stenotrophomonas Maltophilia</Disease_Detail>
      <Disease_DB>STN007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/stenotrophomonas_maltophilia?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Candida Glabrata</Disease_Name>
      <Disease_Detail>Candida Glabrata</Disease_Detail>
      <Disease_DB>CND006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/candida_glabrata?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malaria</Disease_Name>
      <Disease_Detail>Malaria</Disease_Detail>
      <Disease_DB>MLR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malaria?search=DHFR#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Plasmodium Falciparum Malaria</Disease_Name>
      <Disease_Detail>Plasmodium Falciparum Malaria</Disease_Detail>
      <Disease_DB>PLS007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/plasmodium_falciparum_malaria?search=DHFR#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Preferential Selection of Isomer Binding from Chiral Mixtures: Alernate Binding Modes Observed fro the E- and Z-isomers of a Series of 5-Substituted 2,4-Diaminofuro[2,3-d]pyrimidines as Ternary Complexes with NADPH and Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>3NXY</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NXY</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2010)66:1271-1277</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21123866?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Dihydrofolate Reductase Structural Data with Active Site Mutant Enzyme Complexes</PDB_Title>
      <PDB_ID>3F8Z</PDB_ID>
      <Resolution>2.01</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3F8Z</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Correlations of Inhibitor Kinetics for Pneumocystis jirovecii and Human Dihydrofolate Reductase with Structural Data for Human Active Site Mutant Enzyme Complexes.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Biochemistry(2009)48:1702-1711</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19196009?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE, MONOCLINIC (P21) CRYSTAL FORM</PDB_Title>
      <PDB_ID>1OHJ</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1OHJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Biochemistry(1997)36:13897-13903</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9374868?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure Determination of Tetrahydroquinazoline Antifoaltes in Complex with Human and Pneumocystis carinii Dihydrofolate Reductase: Correlations of Enzyme Selectivity and Stereochemistry</PDB_Title>
      <PDB_ID>1S3W</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1S3W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2004)60:646-655</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15039552?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure Determination of Tetrahydroquinazoline Antifolates in Complex with Human and Pneumocystis carinii Dihydrofolate Reductase: Correlations of Enzyme Selectivity and Stereochemistry</PDB_Title>
      <PDB_ID>1S3V</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1S3V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2004)60:646-655</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15039552?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE</PDB_Title>
      <PDB_ID>1DRF</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DRF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human dihydrofolate reductase complexed with folate.</PubMed_Title>
      <Author>Oefner, C., et al.</Author>
      <Journal>Eur.J.Biochem.(1988)174:377-385</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/3383852?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE</PDB_Title>
      <PDB_ID>1DHF</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DHF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate.</PubMed_Title>
      <Author>Davies 2nd., J.F., et al.</Author>
      <Journal>Biochemistry(1990)29:9467-9479</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2248959?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE</PDB_Title>
      <PDB_ID>2W3M</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W3M</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Structural Basis for Selective Inhibition of Mycobacterium Avium Dihydrofolate Reductase by a Lipophilic Antifolate</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE</PDB_Title>
      <PDB_ID>1HFQ</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HFQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Anti-Cancer Drug Des.(1998)13:307-315</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9627670?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Understanding the Role of Leu22 Variants in Methotrexate Resistance: Comparison of Wild-type and Leu22Arg Variant Mouse and Human Dihydrfolate Reductase Ternary Crystal Complexes with Methotrexate and NADPH</PDB_Title>
      <PDB_ID>1U72</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1U72</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2005)61:147-155</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15681865?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE</PDB_Title>
      <PDB_ID>1HFP</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HFP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Anti-Cancer Drug Des.(1998)13:307-315</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9627670?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Correlations of Inhibitor Kinetics for Pneumocystis jirovecii and Human Dihydrofolate Reductase with Structural Data for Human Active Site Mutant Enzyme Complexes</PDB_Title>
      <PDB_ID>3FS6</PDB_ID>
      <Resolution>1.23</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FS6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Correlations of Inhibitor Kinetics for Pneumocystis jirovecii and Human Dihydrofolate Reductase with Structural Data for Human Active Site Mutant Enzyme Complexes.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Biochemistry(2009)48:1702-1711</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19196009?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Design, Synthesis, and X-ray Crystal Structure of Classical and Nonclassical 2-amino-4-oxo-5-substituted-6-thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agenst</PDB_Title>
      <PDB_ID>3GHC</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GHC</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents</PubMed_Title>
      <Author>Gangjee, A., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4892-4902</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19719239?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE-BASED DESIGN AND SYNTHESIS OF LIPOPHILIC 2,4-DIAMINO-6-SUBSTITUTED QUINAZOLINES AND THEIR EVALUATION AS INHIBITORS OF DIHYDROFOLATE REDUCTASE AND POTENTIAL ANTITUMOR AGENTS</PDB_Title>
      <PDB_ID>1BOZ</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BOZ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.</PubMed_Title>
      <Author>Gangjee, A., et al.</Author>
      <Journal>J.Med.Chem.(1998)41:3426-3434</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9719595?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Design, Synthesis, Biological Evaluation and X-ray Crystal Structures of Novel Classical 6,5,6-tricyclicbenzo[4,5]thieno[2,3-d]pyrimidines as Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors</PDB_Title>
      <PDB_ID>3NTZ</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NTZ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.</PubMed_Title>
      <Author>Zhang, X., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2011)19:3585-3594</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21550809?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Perferential Selection of Isomer Binding from Chiral Mixtures: Alternate Binding Modes Observed for the E- and Z-isomers of a Series of 5-Substituted 2,4-Diaminofuro[2,3-d]pyrimidines as Ternary Complexes with NADPH and Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>3NXR</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NXR</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2010)66:1271-1277</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21123866?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO-5-((7,8-DICARBAUNDECABORAN-7-YL)METHYL)-6-METHYLPYRIMIDINE, A NOVEL BORON CONTAINING, NONCLASSICAL ANTIFOLATE</PDB_Title>
      <PDB_ID>2C2T</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2C2T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel Boron-Containing, Nonclassical Antifolates: Synthesis and Preliminary Biological and Structural Evaluation.</PubMed_Title>
      <Author>Reynolds, R.C., et al.</Author>
      <Journal>J.Med.Chem.(2007)50:3283</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17569517?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Preferential Selection of Isomer Binding from Chiral Mixtures: Alternate Binding Modes Observed for the E- and Z-isomers of a Series of 5-Substituted 2,4-Diaminofuro[2,3-d]pyrimidines as Ternary Complexes with NADPH and Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>3NXV</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NXV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2010)66:1271-1277</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21123866?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE REDUCTASE WITH SUBSTITUTION OF LEUCINE 22: KINETICS, CRYSTALLOGRAPHY AND POTENTIAL AS SELECTABLE MARKERS</PDB_Title>
      <PDB_ID>1DLS</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DLS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers.</PubMed_Title>
      <Author>Lewis, W.S., et al.</Author>
      <Journal>J.Biol.Chem.(1995)270:5057-5064</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7890613?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Design, Synthesis, Biological Evaluation and X-ray Crystal Structure of Novel Classical 6,5,6-TricyclicBenzo[4,5]thieno[2,3-d]pyrimidines as Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors</PDB_Title>
      <PDB_ID>3NU0</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NU0</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.</PubMed_Title>
      <Author>Zhang, X., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2011)19:3585-3594</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21550809?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Understanding the Role of Leu22 Variants in Methotrexate Resistance: Comparison of Wild-type and Leu22Arg Variant Mouse and Human Dihydrofolate Reductase Ternary Crystal Complexes with Methotrexate and NADPH</PDB_Title>
      <PDB_ID>1U71</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1U71</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2005)61:147-155</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15681865?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE</PDB_Title>
      <PDB_ID>1HFR</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HFR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Anti-Cancer Drug Des.(1998)13:307-315</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9627670?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Data for Human Active Site Mutant Enzyme Complexes</PDB_Title>
      <PDB_ID>3F91</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3F91</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Correlations of Inhibitor Kinetics for Pneumocystis jirovecii and Human Dihydrofolate Reductase with Structural Data for Human Active Site Mutant Enzyme Complexes.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Biochemistry(2009)48:1702-1711</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19196009?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human dihydrofolate reductase binary complex with PT684</PDB_Title>
      <PDB_ID>3S7A</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3S7A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural analysis of human dihydrofolate reductase as a binary complex with the potent and selective inhibitor 2,4-diamino-6-{2'-O-(3-carboxypropyl)oxydibenz[b,f]-azepin-5-yl}methylpteridine reveals an unusual binding mode.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2011)67:875-880</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21931219?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of a methotrexate-resistant mutant of human dihydrofolate reductase</PDB_Title>
      <PDB_ID>3EIG</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EIG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Multiple conformers in active site of human dihydrofolate reductase F31R/Q35E double mutant suggest structural basis for methotrexate resistance.</PubMed_Title>
      <Author>Volpato, J.P., et al.</Author>
      <Journal>J.Biol.Chem.(2009)284:20079-20089</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19478082?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (Z)-6-(2-[2,5-DIMETHOXYPHENYL]ETHEN-1-YL)-2,4-DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE (SRI-9662), A LIPOPHILIC ANTIFOLATE</PDB_Title>
      <PDB_ID>1KMV</PDB_ID>
      <Resolution>1.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KMV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 a and 1.05 a resolution.</PubMed_Title>
      <Author>Klon, A.E., et al.</Author>
      <Journal>J.Mol.Biol.(2002)320:677-693</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12096917?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE, ORTHORHOMBIC (P21 21 21) CRYSTAL FORM</PDB_Title>
      <PDB_ID>1OHK</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1OHK</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Biochemistry(1997)36:13897-13903</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9374868?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Analysis of Two Polymorphic Forms of a Pyrido[2,3-d]pyrimidine N9-C10 Reverse-Bridge Antifolate Binary Complex with Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>1MVS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MVS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Analysis of two polymorphic forms of a pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolate binary complex with human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2003)59:654-661</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12657784?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human dihydrofolate reductase Q35K mutant inhibitor complex</PDB_Title>
      <PDB_ID>3GI2</PDB_ID>
      <Resolution>1.53</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GI2</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents.</PubMed_Title>
      <Author>Gangjee, A., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4892-4902</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19719239?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Correlations of Human Dihydrofolate Reductase with Structural Data for Human Active Site Mutant Enzyme Complexes</PDB_Title>
      <PDB_ID>3F8Y</PDB_ID>
      <Resolution>1.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3F8Y</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Correlations of Inhibitor Kinetics for Pneumocystis jirovecii and Human Dihydrofolate Reductase with Structural Data for Human Active Site Mutant Enzyme Complexes.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Biochemistry(2009)48:1702-1711</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19196009?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure Determination of Tetrahydroquinazoline Antifolates in Complex with Human and Pneumocystis carinii Dihydrofolate Reductase: Correlations of Enzyme Selectivity and Stereochemistry</PDB_Title>
      <PDB_ID>1S3U</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1S3U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2004)60:646-655</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15039552?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO-5-(1-O-CARBORANYLMETHYL)-6-METHYLPYRIMIDINE, A NOVEL BORON CONTAINING, NONCLASSICAL ANTIFOLATE</PDB_Title>
      <PDB_ID>2C2S</PDB_ID>
      <Resolution>1.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2C2S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel Boron-Containing, Nonclassical Antifolates: Synthesis and Preliminary Biological and Structural Evaluation.</PubMed_Title>
      <Author>Reynolds, R.C., et al.</Author>
      <Journal>J.Med.Chem.(2007)50:3283</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17569517?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE</PDB_Title>
      <PDB_ID>2DHF</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DHF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate.</PubMed_Title>
      <Author>Davies 2nd., J.F., et al.</Author>
      <Journal>Biochemistry(1990)29:9467-9479</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2248959?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE REDUCTASE WITH SUBSTITUTION OF LEUCINE 22: KINETICS, CRYSTALLOGRAPHY AND POTENTIAL AS SELECTABLE MARKERS</PDB_Title>
      <PDB_ID>1DLR</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DLR</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers.</PubMed_Title>
      <Author>Lewis, W.S., et al.</Author>
      <Journal>J.Biol.Chem.(1995)270:5057-5064</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7890613?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Analysis of Three Crystal Structure Determinations of a 5-Methyl-6-N-Methylanilino Pyridopyrimidine Antifolate Complex with Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>1PD8</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PD8</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Analysis of three crystal structure determinations of a 5-methyl-6-N-methylanilino pyridopyrimidine antifolate complex with human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2003)59:1603-1609</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12925791?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Preferential Selection of Isomer Binding from Chiral Mixtures: Alernate Binding Modes Observed fro the E- and Z-isomers of a Series of 5-Substituted 2,4-Diaminofuro[2,3-d]pyrimidines as Ternary Complexes with NADPH and Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>3NZD</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NZD</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2011)67:1-7</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21206056?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>human dihydrofolate reductase Q35K/N64F double mutant binary complex with trimethoprim</PDB_Title>
      <PDB_ID>3S3V</PDB_ID>
      <Resolution>1.53</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3S3V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic analysis reveals a novel second binding site for trimethoprim in active site double mutants of human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>J.Struct.Biol.(2011)176:52-59</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21684339?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR, 6-((2,5-DIETHOXYPHENYL)AMINOMETHYL)-2,4-DIAMINO-5-METHYLPYRIDO(2,3-D)PYRIMIDINE (SRI-8686)</PDB_Title>
      <PDB_ID>2W3B</PDB_ID>
      <Resolution>1.27</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W3B</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Structural Basis for Selective Inhibition of Mycobacterium Avium Dihydrofolate Reductase by a Lipophilic Antifolate</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Structural and Kinetic Data for Antifolate Interactions Against Pneumocystis jirovecii, Pneumocystis carinii and Human Dihydrofolate Reductase and Thier Active Site Mutants</PDB_Title>
      <PDB_ID>3OAF</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OAF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and Kinetic Data for Antifolate Interactions Against Pneumocystis jirovecii,  Pneumocystis carinii and Human Dihydrofolate Reductase and Thier Active Site Mutants</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>hDHFR double mutant Q35S/N64F Trimethoprim Binary Complex</PDB_Title>
      <PDB_ID>3N0H</PDB_ID>
      <Resolution>1.92</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3N0H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic analysis reveals a novel second binding site for trimethoprim in active site double mutants of human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>J.Struct.Biol.(2011)176:52-59</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21684339?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human dihydrofolate reductase inhibitor complex</PDB_Title>
      <PDB_ID>3GHW</PDB_ID>
      <Resolution>1.24</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GHW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents</PubMed_Title>
      <Author>Gangjee, A., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4892-4902</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19719239?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural, Computational and Kinetic Data for Antifolate Interactions Against Pneumocystis jirovecii, Pneumocystis carinii and Human Dihydrofolate Reductase and Their Active Site Mutants</PDB_Title>
      <PDB_ID>3L3R</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3L3R</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Structural, Computational and Kinetic Data for Antifolate Interactions  Against Pneumocystis jirovecci, Pneumocystis carinii and Human Dihydrofolate  Reductase and Their Active Site Mutants</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of human dihydrofolate reductase complexed with trimethoprim and nadph, 25 structures</PDB_Title>
      <PDB_ID>1YHO</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YHO</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Solution structure of human dihydrofolate reductase in its complex with trimethoprim and NADPH.</PubMed_Title>
      <Author>Kovalevskaya, N.V., et al.</Author>
      <Journal>J.Biomol.Nmr(2005)33:69-72</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16222560?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human dihydrofolate reductase Q35K/N64F double mutant inhibitor complex</PDB_Title>
      <PDB_ID>3GHV</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GHV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents</PubMed_Title>
      <Author>Gangjee, A., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4892-4902</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19719239?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human DHFR with Z-isomer in Orthorhombic lattice</PDB_Title>
      <PDB_ID>3GYF</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GYF</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>The Z isomer of 2,4-diaminofuro[2,3-d]pyrimidine antifolate promotes unusual crystal packing in a human dihydrofolate reductase ternary complex.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.F(2009)65:762-766</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19652333?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Preferential Selection of Isomer Binding from Chiral Mixtures: Alternate Binding Modes Observed for the E-and Z-isomers of a Series of 5-substituted 2,4-diaminofuro[2m,3-d]pyrimidines as Ternary Complexes with NADPH and Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>3NXT</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NXT</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2010)66:1271-1277</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21123866?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Analysis of Three Crystal Structure Determinations of a 5-Methyl-6-N-Methylanilino Pyridopyrimidine antifolate Complex with Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>1PD9</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PD9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Analysis of three crystal structure determinations of a 5-methyl-6-N-methylanilino pyridopyrimidine antifolate complex with human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2003)59:1603-1609</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12925791?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM</PDB_Title>
      <PDB_ID>2W3A</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W3A</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Structural Basis for Selective Inhibition of Mycobacterium Avium Dihydrofolate Reductase by a Lipophilic Antifolate</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-([5-QUINOLYLAMINO]METHYL)-2,4-DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE (SRI-9439), A LIPOPHILIC ANTIFOLATE</PDB_Title>
      <PDB_ID>1KMS</PDB_ID>
      <Resolution>1.09</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KMS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 a and 1.05 a resolution.</PubMed_Title>
      <Author>Klon, A.E., et al.</Author>
      <Journal>J.Mol.Biol.(2002)320:677-693</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12096917?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Analysis of Three Crystal Structure Determinations of a 5-Methyl-6-N-Methylanilino Pyridopyrimidine Antifolate Complex with Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>1PDB</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PDB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Analysis of three crystal structure determinations of a 5-methyl-6-N-methylanilino pyridopyrimidine antifolate complex with human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2003)59:1603-1609</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12925791?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Perferential Selection of Isomer Binding from Chiral Mixtures: Alternate Binding Modes Observed for the E- and Z-isomers of a Series of 5-Substituted 2,4-Diaminofuro[2,3-d]pyrimidines as Ternary Complexes with NADPH and Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>3NXO</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NXO</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2010)66:1271-1277</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21123866?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Analysis of Two Polymorphic Forms of a Pyrido[2,3-d]pyrimidine N9-C10 Reverse-Bridge Antifolate Binary Complex with Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>1MVT</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MVT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Analysis of two polymorphic forms of a pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolate binary complex with human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2003)59:654-661</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12657784?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Preferential Selection of Isomer Binding from Chiral Mixtures: Alternate Binding Modes Observed for the E- and Z-isomers of a Series of 5-Substituted 2,4-Diaminofuro-2,3-d]pyrimidines as Ternary Complexes with NADPH and Human Dihydrofolate Reductase</PDB_Title>
      <PDB_ID>3NXX</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NXX</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01500001</ASD_Ligand>
      <PubMed_Title>Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.</PubMed_Title>
      <Author>Cody, V., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2010)66:1271-1277</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21123866?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00790</Pathway_ID>
      <Pathway_Title>Folate biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of cofactors and vitamins</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00670</Pathway_ID>
      <Pathway_Title>One carbon pool by folate</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of cofactors and vitamins</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00790</Pathway_ID>
      <Pathway_Title>Folate biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of cofactors and vitamins</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00670</Pathway_ID>
      <Pathway_Title>One carbon pool by folate</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of cofactors and vitamins</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00790</Pathway_ID>
      <Pathway_Title>Folate biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of cofactors and vitamins</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00670</Pathway_ID>
      <Pathway_Title>One carbon pool by folate</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of cofactors and vitamins</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.bac.b.b.i.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1boz</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,10,Ala;site,17,Ile;site,22,Asp;site,55,Lys;site,57,Thr;site,76,Leu;site,77,Ser;site,78,Arg;site,118,Gly;site,119,Ser;site,120,Ser</Site_Detail>
      <Site_Reference>Lewis WS, et al. J Biol Chem. 1995,270(10):5057-5064.</Site_Reference>
      <Site_Type>sector connectivity</Site_Type>
      <PDB_ID>1BOZ;1DLR;1DLS;1KMS;1KMV;1OHJ;1OHK;1PD8;1U72;1YHO;2C2S;2C2T;2W3A;2W3B;2W3M;3F8Y;3F8Z;3F91;3FS6;3GHC;3GHV;3GHW;3GI2;3GYF;3L3R;3NTZ;3NU0;3NXO;3NXR;3NXT;3NXV;3NXX;3NXY;3NZD</PDB_ID>
      <PubMed_ID>7890613</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.5.1.3</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/5/1/3.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01500001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04670001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04670002</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>